Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
8.0%
% of IXJ's 112 holdings also in XDNA
39.1%
% of XDNA's 23 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 4.0% | 3.8% | 3.8% |
 |
NOVARTIS AG | 2.8% | 3.0% | 2.8% |
|
THERMO FISHER SCIENTIFIC INC | 2.7% | 9.5% | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 1.5% | 1.5% |
 |
SANOFI-AVENTIS | 1.5% | 3.2% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to XDNA
|
ELI LILLY & CO | 9.0% |
|
UNITEDHEALTH GROUP INC | 6.8% |
 |
NOVO NORDISK A/S-B | 5.5% |
|
JOHNSON & JOHNSON | 4.8% |
|
MERCK & CO. INC. | 4.2% |
 |
ASTRAZENECA PLC | 3.2% |
|
ROCHE HOLDING LTD | 2.9% |
|
AMGEN INC | 2.3% |
|
ABBOTT LABORATORIES | 2.3% |
|
PFIZER INC | 2.2% |
IXJ Underweight Relative to XDNA
|
CRISPR THERAPEUTICS AG | -15.1% |
|
BEAM THERAPEUTICS, INC. | -13.7% |
|
INTELLIA THERAPEUTICS, INC. | -8.7% |
|
THERMO FISHER SCIENTIFIC INC | -6.8% |
|
PRIME MEDICINE, INC. | -5.9% |
|
EDITAS MEDICINE, INC. | -5.7% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
VERVE THERAPEUTICS, INC. | -4.5% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
|
ALLOGENE THERAPEUTICS, INC. | -3.4% |